Moderate riskFDA DrugClass II

Blaine Labs TERPENICOL antifungal recalled for CGMP deviations

Blaine Labs is recalling TERPENICOL Antifungal Solution (1.0 fl oz bottles) because of CGMP deviations: the firm discontinued required stability testing for products still within expiry. The recall covers three lots distributed nationwide, 5,801 bottles in total. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Stop using TERPENICOL Antifungal Solution from the affected lots.
  2. Check the lot number and expiration date on the bottle. Affected lots are BL3411R (exp 06/08/2027), BL3468 (exp 03/07/2027) and BL3535 (exp 09/25/2027), NDC 63347-600-01.
  3. The notice doesn't say how to get a refund or replacement or where the product was sold; ask the place you bought it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
TERPENICOL Antifungal Solution, (Undecylenic (10-Undecenoic) acid 25%), 1.0 Fl Oz (29.6 mL), Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Santa Fe Springs, CA 90670. NDC 63347-600-01
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 8 products — see all of them.

Details

Units affected
5,801 bottles
Illnesses reported
None reported
Manufactured in
11037 Lockport Pl, N/A, Santa Fe Springs, CA, United States
Classification
Class II
Recall number
D-0697-2026

In the FDA's words

Description
TERPENICOL Antifungal Solution, (Undecylenic (10-Undecenoic) acid 25%), 1.0 Fl Oz (29.6 mL), Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Santa Fe Springs, CA 90670. NDC 63347-600-01 CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry Lots BL3411R, Exp Date 06/08/2027, BL3468, Exp Date 03/07/2027, & BL3535, Exp Date 09/25/2027. Distribution: Nationwide in the USA Affected quantity: 5,801 bottles
Hazard
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

8 products in this recall

Revitaderm, Terpenicol and more recalled for microbial contamination

Eight Blaine Labs and Trifluent Pharma wound care and antifungal products are recalled: Revitaderm, TRIDERGEL, TRIPENICOL S, TERPENICOL, vite20, Fungal Fusion and Revitaderm First Aid Antiseptic Gel. Samples of these non-sterile products showed Lysinibacillus fusiformis and other Bacillus species. The FDA has classified this as a Class I recall.

The agency lists each product separately. Check every one you might have.

Related topics

OtherDrugsSold nationwideMore from FDA Drug